BlackBerry Limited vs Medtronic PLC — how do they compare? BlackBerry Limited trades at $9.15 (market cap $5.18B), while Medtronic PLC trades at $90.48 (market cap $114.45B). The key difference: Medtronic PLC is far larger — about 22.1× BlackBerry Limited's market cap, and Medtronic PLC pays a 3.22% dividend while BlackBerry Limited pays none. Which is the better fit depends on your goals.
| BB | MDT | |
|---|---|---|
Market Cap | $5.18B | $114.45B |
Sector | Technology | Health |
52-Week High | $12.81 | $105.35 |
52-Week Low | $3.15 | $73.75 |
Enterprise Value | $5.05B | $133.19B |
Dividend Yield | — | 3.22% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Medtronic (MDT) trades at $87.16, up 1.44% today, with a bullish technical signal and consistent earnings beats. The company reported Q1 2026 EPS of $1.55, exceeding expectations, and maintains solid fundamentals with a 13.2% net income margin and $33.54B in revenue for 2025. Recent news highlights growth in cardiac ablation and the Hugo robotic platform, with management guiding for 11.75% organic revenue growth in Q1 2027.
The outlook is positive, supported by analyst consensus of a $98.75 price target and 60% buy ratings. Key opportunities include dividend stability and innovation in medical technology, while risks involve rising debt levels and competitive pressures. The stock's current valuation at a P/E of 23.37 offers moderate upside if execution continues.
Trailing returns across standard periods
Latest headlines on both assets
BlackBerry Limited provides intelligent security software solutions. The Company offers artificial intelligence and machine learning for cybersecurity, safety, and data privacy solutions, as well as endpoint security and management, encryption, and embedded systems. BlackBerry serves governments and enterprise sectors worldwide.
Read more on BB →One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →